Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Wang Liqiang, Executive. Officer active across 2 companies, notably RemeGen Co., Ltd.. In total, 18 filings have been logged. History available since 31 March 2026. The latest transaction was filed on 8 July 2026 (Sale). Regulator: HKEX. The full history is accessible without signup.
186,000 shares@ €10.58450.0039% mcap26.6% of flowShareXHKGHKEX:DA20260402E00167
18 of 18 declarations
About Wang Liqiang
Liqiang Wang is an executive at RemeGen Co., Ltd. - H Shares, a company active in the biopharmaceutical sector. In his role, he oversees the company's operations and strategy, contributing to innovation in drug development. His experience in the sector is an asset for the company's growth.